VIJAY U RAO
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease INDIANAPOLIS, IN NPI 1811158488
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease IN Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$323,719.58
- Category: General Payments
- Program years: PY2018–2024
- Record count: 584
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $16,042.67 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,975.00 | 7 |
| Food and Beverage | $1,011.39 | 34 |
| Travel and Lodging | $56.28 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,155.73 | 8 |
| SCPHARMACEUTICALS INC. | $4,995.63 | 6 |
| PFIZER INC. | $3,506.31 | 11 |
| Lilly USA, LLC | $900.00 | 1 |
| CVRx Inc. | $112.71 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $99.79 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $67.24 | 4 |
| Novo Nordisk AS | $41.25 | 2 |
| E.R. Squibb & Sons, L.L.C. | $33.66 | 2 |
| Acerta Pharma LLC | $32.53 | 1 |
| Kiniksa Pharmaceuticals International, plc | $29.55 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $19.93 | 1 |
| Amgen Inc. | $18.69 | 1 |
| Merck Sharp & Dohme Corporation | $15.49 | 1 |
| Lexicon Pharmaceuticals, Inc. | $14.16 | 1 |
By program year
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.